Midterm Outcomes of Root Replacement Using Homograft for Aortic Valve Infective Endocarditis

From August 2003 to June 2013, 9 patients with aortic valve endocarditis underwent aortic root replacement using homografts which were harvested and preserved in our institute. The median patient age was 62 years (range 46~84) and 5 patients were men. Four cases were prosthetic valve infections. The...

Full description

Saved in:
Bibliographic Details
Published inKyobu geka. The Japanese journal of thoracic surgery Vol. 68; no. 11; p. 903
Main Authors Tsuda, Yasutoshi, Yokoyama, Takahito, Kawai, Yujiro, Niitsu, Hirokazu, Toyoda, Yasuyuki, Shiratori, Kazuaki, Takemura, Takahiro
Format Journal Article
LanguageJapanese
Published Japan 01.11.2015
Subjects
Aged
Aortic Valve - physiopathology
Aortic Valve - surgery
Aortic Valve - transplantation
Bicuspid Aortic Valve Disease
Endocarditis, Bacterial - surgery
Female
Heart Defects, Congenital - physiopathology
Heart Defects, Congenital - surgery
Heart Valve Diseases - physiopathology
Heart Valve Diseases - surgery
Humans
Male
Middle Aged
Postoperative Complications - surgery
Tissue Preservation - instrumentation
Transplantation, Homologous
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:From August 2003 to June 2013, 9 patients with aortic valve endocarditis underwent aortic root replacement using homografts which were harvested and preserved in our institute. The median patient age was 62 years (range 46~84) and 5 patients were men. Four cases were prosthetic valve infections. The in-hospital mortality was 0%. In 8 of 9 cases were evaluated on midterm outcomes. At a median of 52 months (range 19~156), overall survival was 100%, freedom from cardiovascular events was 87.5%. The peak aortic pressure gradient was 9.04 ± 4.2 mmHg. Aortic regurgitation was less than 2 of 4 in all cases.
ISSN:0021-5252